CastaldiPartners on the recapitalization of MicroPort® CRM group

CastaldiPartners has advised MicroPort Cardiac Rhythm Management («MicroPort® CRM»), a pioneer in the research and development of solutions for the management of cardiac rhythm disorders and subsidiary of MicroPort Scientific Corporation («MicroPort®»), in the post-closing operations of the financing agreements totalling USD 105 million.

Gaspare Dori and Leïla Haye of CastaldiPartners advised the MicroPort® CRM group on the recapitalization of its French subsidiaries and one of its Dutch subsidiaries, in collaboration with Houthoff, with a team composed of Paul de Vries and Thomas de Rave. The Legal Affairs Department and the Finance Department of the MicroPort® CRM group was involved with Alice Flacco (General Counsel) and Paul Vodden (Finance Director).